TICE BCG VIAL 50MG/2ML(BCG LIVE)

Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.

Brand	TICE BCG
Manufacturer	MERCK SHARP AND DOHME DE ESPAÑA, S.A.
Prescription required	Yes

Description

TICE BCG VIAL 50MG/2ML(BCG LIVE) is a medicine catalog record in the MediPriceHub database. Active ingredient: BCG LIVE. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: MERCK SHARP AND DOHME DE ESPAÑA, S.A.. Therapeutic category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Pack information: 50 / 2. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

TICE ® BCG is indicated for: the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR) Limitations of Use: TICE BCG is not recommended for stage TaG1 papillary tumors, unless they are judged to be at high risk of tumor recurrence. TICE BCG is not indicated for papillary tumors of stages higher than T1.

How to Use

NDC 0052-0602-02 (for Intravesical Use) Single-Dose Vial

Specification

Active ingredient: BCG LIVE. Pack size: 50 / 2. Pack unit: bottle. Manufacturer: MERCK SHARP AND DOHME DE ESPAÑA, S.A.. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.